Understanding HIV-1 Latent Reservoir Persistence
Author Information
Author(s): Kim Hwijin, Alan S. Perelson
Primary Institution: Los Alamos National Laboratory
Hypothesis
What factors contribute to the persistence of latently infected cells in HIV-1 patients on therapy?
Conclusion
The study reveals that T cell bystander proliferation and latent cell activation are key factors in maintaining the latent reservoir and low-level viremia in HIV-1 patients.
Supporting Evidence
- Latently infected cells can proliferate without producing virus.
- Activation of latently infected cells decreases over time on therapy.
- High drug efficacy can maintain low viral loads without depleting the latent reservoir.
Takeaway
Even with treatment, some HIV can hide in the body and stay there for a long time, making it hard to get rid of the virus completely.
Methodology
A mathematical model was developed to analyze the dynamics of HIV-1 and latently infected cells during antiretroviral therapy.
Limitations
The model assumes constant parameters and does not account for all potential variations in patient responses.
Participant Demographics
Patients who initiated treatment during primary infection.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website